A full range of preclinical and safety evaluation services to meet the pharmaceutical, biotech, chemical, cosmetics, medical device companies requirements.
Don't miss Citoxlab webinar on ''Experience and Perspectives on OECD 443, the Extended One-Generation Reproductive Toxicity Study''
#toxicity#cancer#health#howto#reproduction#safety https://t.co/8SZWlMInuH
The Citoxlab team will be pleased to meet with you next week during the SPS Annual Meeting in Washington, DC. Stop by booth #109!
We will be presenting 8 scientific posters. Click here for more info : https://t.co/M8rBSbEV9W
#SPSannualmeeting#safetypharmacology
FINAL PROGRAM for the Boston Symposium on September 13th! Registration : https://t.co/ozNi29JeoC or contact Raluca Kubaszky, DVM, PhD, DABT at [email protected] for all the details and additional information.
|| NEWS || : Citoxlab appoints Christophe Berthoux as CEO, Europe
This appointment will further drive current and future development of Citoxlab's European sites, which are already experiencing strong growth
Read more : https://t.co/MsnJJUDRlL
|| Eurotox 2018 || : Drop by booth #17 - #18 to meet our team of specialists during the 54th Congress of the European Societies of Toxicology (EUROTOX). We will be presenting scientific posters - Abstracts : https://t.co/IQH1mgr8FJ
|| News || : The Scientific Board of Ellegaard Göttingen Minipigs Research Foundation granted €35,000 to the project “Speedgene targeted knock out of the PCSK-9 gene in Göttingen Minipigs”, and the research teams behind the project. Read more : https://t.co/IqyhOrEsae
|| NEWS || : Do you want to know more about the CiPA landscape? Read our article by Dr Simon Authier, Dr Hai Huang and Dr Michael Accardi
https://t.co/SeKKhwyeiR
|| Eurotox 2018 || : Join us on Monday, September 3rd for the Citoxlab Industry Symposium about advances in immulogical safety evaluation of immunomodulatory drugs.
More information and registration : https://t.co/IQH1mgr8FJ
Perturbateur endocrinien : Entrée en vigueur du règlement (n°2017/2100) permettant la détermination des propriétés perturbateur endocrinien dans le co https://t.co/XC5lYNKF1B
Le centre d’Évreux (Eure) vient d’acquérir un laboratoire hongrois qui complète son offre de recherche sur le champ pharmaceutique. Il emploie 350 personnes sur son site historique normand. https://t.co/YixA3zgXxH https://t.co/s0naj3aAhM